Skip to main content

dapirolizumab pegol

dapirolizumab pegol: sourced relationships with 1 company · 1 clinical trial tracked.

dapirolizumab pegol evidence translation

What we can confirm

1 tracked trial

What it means

Source-backed records connect dapirolizumab pegol to BIIB; that link alone does not prove the drug works.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

How could dapirolizumab pegol → BIIB affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Related indications

moderate-to-severe systemic lupus erythematosusSystemic Lupus Erythematosus

Study sponsors

No additional listed-company sponsor is linked.

Dated Pipeline Records (1)
CompanyDated record stage
BIOGEN INC. (BIIB)
co_developer · Reported 2025-02-12 · Current development: unknownSource
moderate-to-severe systemic lupus erythematosus
Phase 3
Clinical Trial Registry Records (1)

A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Dapirolizumab Pegol Treatment in Study Participants With Systemic Lupus Erythematosus

NCT04976322Registry updated 2026-06-12·Phase 3
Enrolling by invitation

Primary endpoint: Incidence of treatment-emergent adverse events (TEAEs) during the study

Interventionalopen760 targetStarted 2021-07Completion 2030-0850 sites · Argentina, Belgium, Bulgaria, Canada…UCB Biopharma SRL

Frequently asked questions

Which companies have sourced relationships with dapirolizumab pegol?

dapirolizumab pegol has dated SEC/FDA relationship records for BIOGEN INC..

How many clinical trials involve dapirolizumab pegol?

BioSniper tracks 1 clinical trial involving dapirolizumab pegol.